Peritoneal Perivascular Epithelioid Cell Tumor with Pulmonary Metastasis

Inês Margarida Neves Gomes, Ana Cristina Da Costa Ferreira De Vilhena, Inês Calvinho de de OLIVEIRA, Pedro Martinho SANTOS SEQUEIRA, Jorge Da Cunha Oliveira, C. Vinagre
{"title":"Peritoneal Perivascular Epithelioid Cell Tumor with Pulmonary Metastasis","authors":"Inês Margarida Neves Gomes, Ana Cristina Da Costa Ferreira De Vilhena, Inês Calvinho de de OLIVEIRA, Pedro Martinho SANTOS SEQUEIRA, Jorge Da Cunha Oliveira, C. Vinagre","doi":"10.5336/jcog.2021-86575","DOIUrl":null,"url":null,"abstract":"32 Perivascular epithelioid cell tumor (PEComa) is part of a rare family of mesenchymal tumors. PEComas occur at multiple sites and can undergo metastasis, recurrence, and aggressive clinical courses. The lung is a common metastatic site of PEComas. The role of estrogen in PEComas is unclear. In humans, estrogen might stimulate PEComa tumour cells because of a mutation in the TSC2 tumour suppressor gene, through MEK pathway.1 Blocking estrogen receptors might therefore inactivate the MEK pathway and provide a rationale for therapeutic efficacy.1 There are few reports about uterine malignant PEComa tumours with pulmonary metastases and fewer about the use of hormonal therapy, including tamoxifen.1-5 We report a case of a malignant peritoneal PEComa with pulmonary metastasis which has been treated for 2 years with tamoxifen and to the date the patient is alive and well, with a controlled disease.","PeriodicalId":137134,"journal":{"name":"Journal of Clinical Obstetrics & Gynecology","volume":"100 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Obstetrics & Gynecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5336/jcog.2021-86575","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

32 Perivascular epithelioid cell tumor (PEComa) is part of a rare family of mesenchymal tumors. PEComas occur at multiple sites and can undergo metastasis, recurrence, and aggressive clinical courses. The lung is a common metastatic site of PEComas. The role of estrogen in PEComas is unclear. In humans, estrogen might stimulate PEComa tumour cells because of a mutation in the TSC2 tumour suppressor gene, through MEK pathway.1 Blocking estrogen receptors might therefore inactivate the MEK pathway and provide a rationale for therapeutic efficacy.1 There are few reports about uterine malignant PEComa tumours with pulmonary metastases and fewer about the use of hormonal therapy, including tamoxifen.1-5 We report a case of a malignant peritoneal PEComa with pulmonary metastasis which has been treated for 2 years with tamoxifen and to the date the patient is alive and well, with a controlled disease.
腹膜血管周围上皮样细胞瘤伴肺转移
血管周围上皮样细胞瘤(PEComa)是一种罕见的间充质肿瘤。PEComas发生在多个部位,可发生转移、复发和侵袭性的临床过程。肺是PEComas最常见的转移部位。雌激素在PEComas中的作用尚不清楚。在人类中,雌激素可能通过MEK途径刺激PEComa肿瘤细胞,因为TSC2肿瘤抑制基因发生突变因此,阻断雌激素受体可能使MEK通路失活,并为治疗效果提供了理论依据关于子宫恶性PEComa合并肺转移的报道很少,使用激素治疗(包括他莫昔芬)的报道也较少。1-5我们报告一例恶性腹膜PEComa伴肺转移的病例,该病例已接受他莫昔芬治疗2年,到目前为止患者还活着,病情得到控制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信